跳至主要内容
临床试验/NCT01395381
NCT01395381撤回不适用

Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Benefit of Antihelminthic Therapy in the Community-Based Treatment of Severe Acute Malnutrition in Malawian Children

Washington University School of Medicine1 个研究点 分布在 1 个国家开始时间: 2013年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
撤回
试验地点
1
主要终点
nutritional recovery

研究概览

简要总结

The benefit of anti-worm therapy as part of the case management of severe acute malnutrition (SAM) in the outpatient setting has not previously been studied. This study will compare recovery rates of children with SAM treated in the community with locally-produced ready-to-use therapeutic food (RUTF) with and without prescribed albendazole as part of their case management.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
6 Months 至 59 Months(Child)
性别
All
接受健康志愿者

入选标准

  • 12-59 months old
  • Kwashiorkor and/or Marasmus
  • Qualified for home-based therapeutic feeding with RUTF

排除标准

  • Obvious congenital or other malformation that makes child a poor candidate for feeding with RUTF
  • Unable to consume test-dose of RUTF in clinic
  • Parent refusal to participate and return for follow-up

研究组 & 干预措施

Placebo

Placebo Comparator

干预措施: Placebo (Drug)

Albendazole

Experimental

干预措施: Albendazole (Drug)

结局指标

主要结局

nutritional recovery

时间窗: 12 weeks

Weight-for-Height Z-score (WHZ) \> -2 without bipedal pitting edema

mortality

时间窗: 12 weeks

次要结局

  • malnutrition relapse(6 months)
  • height and weight gain(6 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验